Fact CheckerSign in

NCT04834635Completed

The FundoRingOAGB Versus Non-wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass

The Total Wrapping of the Fundus of the Gastric Excluded Part (FundoRing) Versus Non- Wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass/Mini - Gastric Bypass: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 19 May 2026

Brief summary (registry, in English)

Currently, one anastomosis gastric bypass (OAGB) or mini-gastric bypass (MGB) is a common bariatric procedure for treating obesity. Weight gain after surgery is a big problem in bariatric practice. Therefore, adjustable bands and rings are used, for example, "FobiRing". But foreign material can cause complications - the erosion of the stomach wall. For this reason, surgeons avoid the use of various mechanical devices on living tissues. The greatest criticism is of the OAGB for the likelihood of biliary reflux. In case of reflux of bile into the esophagus after surgery, as a rule, a second operation is required with conversion OAGB to the Roux-en-Y method. In addition, along with obesity, gastroesophageal reflux disease (GERD) are steadily increasing world weight and antireflux surgery must be performed simultaneously with bariatric surgery in obese patients. In these cases, most often in bariatric practice, hiatus cruroraphy is performed, and less often fundoplication using the fundus of the excluded part of the stomach. We hypothesize that total fundoplication can not only treat GERD but also significant prevent the return of weight like after a banded gastric bypass and prevent postoperative bile reflux in the esophagus. The aim study is to compare primary outcome as weight loss after total wrapping of the fundus of the gastric excluded part (FundoRing) and non - wrapping (non - banded) standard method of laparoscopic one anastomosis gastric bypass and measure secondary outcome: bile reflux in the esophagus and GERD symptoms. Methods: Adult participants (n=1000) are randomly allocated to one of two groups: Experimental surgical bariatric procedure in the first (A) group: patients (n=500) undergo the laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric excluded part and suture cruroplasty if present hiatal hernia (FundoRingOAGB group); Active comparator surgical bariatric procedure in the second (B) group: patients (n=500) undergo the laparoscopic one anastomosis gastric bypass and with only suture cruroplasty if present hiatal hernia (OAGB group).

Status (registry)
Completed
Study type
Interventional
Enrollment
1000 (actual)
First submitted
4 Apr 2021
Start date
29 Mar 2021
Primary completion date
5 Apr 2024
Lead sponsor
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
Diseases
Obesity
NCT number
NCT04834635

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1000
  • From 29 Mar 2021 to the primary completion date, 5 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Not fit for bariatric surgery

Other illness

  • History of surgery on the stomach or esophagus
  • Psychiatric illness

Age

  • Less than 18 or more than 60 years of age

Other

  • BMI less than 30 kg / m2 and more than 50 kg / m2.
  • Prosthetic (mesh) Hiatal herniorrhaphy or large hiatal hernia;
  • Esophageal shortening
  • Los Angeles Classification of Oesophagitis (LA grade) C or D reflux esophagitis
  • Patients unwilling or unable to provide informed consent

Who the study is looking for

  • BMI from 30 to 50 kg / m2.
  • The person is generally fit for anesthesia (ASA grading 1-2) and surgery.
  • The person commits to the need for long-term follow-up.

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Oral Ospanov
Coordinator of this site? Confirm its status
AstanaKazakhstanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.